Navigation Links
QualCraft™ Radiation Protection Eyewear -- Metal

ProductsQualCraft™ Radiation Protection Eyewear -- Metal
Company AliMed, Inc.
Item QualCraft™ Radiation Protection Eyewear -- Metal
Features 
  • Metal Lightweight.
  • Black with bronze temple bar
  • Metal Shield Same as above w/mated side shields
  • Metal Oval fits smaller face. Gold w/tortoise rim
  • Metal Oval Shield Same as above w/mated side shields
  • Description QualCraft™ Radiation Protection Eyewear providex maximum comfort and eye protection! Lenses made of 0.75 mm leaded glass. Side shields of 0.30 mm leaded acrylic help seal out scatter radiation and provide excellent peripheral vision.
    Info AliMed, Inc.
    Customer Service: (800) 225-2610
    Web site: http://www.alimed.com/

    Related medicine products :

    1. QualCraft™ Thyroid Shield
    2. QualCraft™ Metal Oval W/Shield
    3. QualCraft™ Euro Lite
    4. QualCraft™ Knee w/MultiLock Polyamide Hinge
    5. QualCraft™ Cubital Tunnel Splint
    6. QualCraft™ Gamekeeper Thumb Stabilizer
    7. Qualcraft™ Lead-Free Back-Aid Radiation Protection Apron
    8. Full-Height Radiation Barriers
    9. MarShields Lead Radiation Shields & Barriers
    10. Radiation Readers, Bifocals - Wraparound
    11. Radiation Readers, Bifocals - Carbon
    This device is a qualitative immunoassay intended to be used to inspect the,overdose usage of cocaine by detecting the benzoylecgonine, a metabolite of,cocaine, in human urine at a cutoff level of 30
    The RapidBZO test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of Benzodiazepines and their metabolites in human,urine specimens above a cut-o
    ...ied Biosystems introduced the completely automated...,Now the innovative technology of the 3100 instr...RISM 3100-Avant Genetic,Analyzer. Designed for l...ly automated 3100-Avant system can analyze,hundr...
    AcT diff2 delivers performance, value and safety for physician office labs and smaller laboratories. It's an affordable, easy-to-use system that offers a small sample volume in both open and closed a
    Medicine Products:
    (Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
    (Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
    (Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
    (Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
    Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
    ...lar retailer in Mexico has opened the channels to ...rugs costing// as less as $3.50. This move has el...s a great way to avail facilities under one roof. ...al-Mart Stores Inc. led the way with a similar mov...
    ... had carried a story about Wal-mart’s foray into h...ilot project which involved the lease of medical s...clinics actively functioning at the Wal mart store...g the meeting of the 4th Annual World Health Care ...
    ...ious researches have authenticated about the benef...out// the dangerous side effects it poses. Scient...s found in green tea could help prevent coronary a... drinking tea could help fight against autoimmune ...
    ...tudy on the effects of the morphine drug shows tha...stem there is still a persistent effect of the dru...tually distorted the neural pathways that control ...se of morphine injected into the rat was still low...
    Other Medicine News:Health News:Dangerous Side Effects of Tea Exposed 2
    (Date:8/19/2008)..., Donated blood and tissue samples to be used to ...se, CAMBRIDGE, Mass., Aug. 19 /PRNewswire-USNewsw...) announced today the acceleration of an ALS,bioma...an expanded network,of clinical partnerships. Thes...ensive effort to indentify the altered expression ...
    (Date:8/18/2008)... SAN DIEGO, Aug. 18 /- The next ti...le nodding off, it might be worth counting sheep,i...c Sleep Center in San,Diego, Calif. has found evid...ease the risk of skin cancer., Daniel F. Kripke, ...involving sleeping pills and cancer, has just been...
    (Date:8/18/2008)... Initiates Clinical Trials Phase of Test De... /- Beckman,Coulter, Inc. (...eement to,buy out its U.S. royalty obligation to N...y focused on women,s health. The license is for te...assessment of preeclampsia, a,leading cause of mat...
    (Date:8/17/2008)... SYDNEY, Australia, Aug. 17 /Xinhua-PRNewswire-...oday announced that the first pivotal Phase 3,clin...ic fibrosis has,completed enrolment., The first e...lable,during the first half of 2009. The trial com... initial recruitment target of 250 subjects in Jun...
    Breaking Medicine Technology:ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 2ALS Therapy Development Institute Partners with Clinical Centers to Establish Pathological Mechanisms of Lou Gehrig's Disease 3Prescription Sleeping Pill Use Tied to Cancer 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment 2Amylin Pharmaceuticals to Webcast Third Quarter Results 3514 1Amylin Pharmaceuticals to Webcast Third Quarter Results 3514 2Hooper Holmes Concludes Sale of Medicals Direct 3511 1Hooper Holmes Concludes Sale of Medicals Direct 3511 2Sue Birth Control Companies for Your Health Says American Life League 3508 1Sue Birth Control Companies for Your Health Says American Life League 3508 2Sue Birth Control Companies for Your Health Says American Life League 3508 3Sue Birth Control Companies for Your Health Says American Life League 3508 4New Executive Market Summaries Offer Concise Disease and Treatment Overviews 1225 1
    ...ings from the ASSERT Trial Presented at EULAR, BAR.../ -- Data,presented today at the European League A... of Rheumatology showed that patients with,ankylos...liximab),over two years experienced significant im...E-treated patients showed sustained,reductions in ...
    ...VERN, Pa., June 15, 2007 /PRNewswire/ -- Solstice,...ts from a,multicenter, forced dose escalation stud...yobloc(R)) recently presented at the 11th,Internat...n,Istanbul, Turkey. , This was the first multicent... escalating treatment doses of 10,000 Units, 12,50...
    Other Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 2Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 3Solstice Neurosciences Presents Escalating Dose Study at,International Congress in Istanbul, Turkey 4